T 1875/19 (Bispecific cross-species-specific antibodies/AMGEN) of 15.11.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T187519.20221115
- Date of decision
- 15 November 2022
- Case number
- T 1875/19
- Petition for review of
- -
- Application number
- 06806155.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions comprising cross-species-specific antibodies and uses thereof
- Applicant name
- Amgen Research (Munich) GmbH
- Opponent name
- Aptevo Research & Development LLC
MorphoSys AG (Opposition withdrawn) - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Sufficiency of disclosure - reproducibility (no)
Statement of grounds of appeal - party's complete case (no)
Late-filed requests
Late-filed request - requests could have been filed in first instance proceedings (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.